Archimedes Pharma logo

Archimedes Pharma

Specialty pharmaceutical company developing therapeutics for the treatment of chronic and debilitating illnesses

30 employees · est. 2004 · Reading, United Kingdom

VS
Disruptive Pharma AB logo

Disruptive Pharma AB

Creating a pipeline of drug products based on our novel drug delivery platform

17 employees · est. 2021 · Stockholm, Sweden

Archimedes Pharma is the older company (2004 vs 2021).

Side-by-Side Comparison

Archimedes Pharma Disruptive Pharma AB
Founded
2004 older 2021
Headquarters
Reading, United Kingdom Stockholm, Sweden
Employees
30 17
Industry
Biotechnology, Health Care, Pharmaceutical Manufacturing, Pharmaceutical
Funding Stage
Acquired Not tracked yet
Total Funding
$329.00M Not tracked yet
Funding Rounds
2 Not tracked yet
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Specialty Pharmaceuticals, Chronic Illness Therapeutics, Oncology, Pain Management, Critical Care, Drug Delivery Technologies, Innovative Treatments, Gliadel, Sustained Release Morphine, Nausea And Vomiting In Cancer, Acute Alcohol Withdrawal, Intranasal Fentanyl, Pharmaceutical Development, European Biopharmaceutical, Patient-Centric Approach Novel Drug Delivery Technology, Pharmaceutical Development, Mesoporous Magnesium Carbonate, Amorphous Solid Dispersions, Therapeutic Drug Products, Spin-out Company, Material Science, Drug Formulation, API Combination, Drug Absorption Enhancement
Website
archimedespharma.com disruptivepharma.com
Archimedes Pharma logo

About Archimedes Pharma

Archimedes Pharma, founded in 2004, is a specialty pharmaceutical company headquartered in the United Kingdom. The company's slogan, "Specialty pharmaceutical company developing therapeutics for the treatment of chronic and debilitating illnesses," encapsulates its mission to deliver pioneering trea...

Disruptive Pharma AB logo

About Disruptive Pharma AB

Disruptive Pharma AB is a pharmaceutical startup with a focus on developing innovative drug products through a unique drug delivery technology. The company's proprietary drug delivery platform, pharma-grade mesoporous magnesium carbonate (Pharma-MMC), sets it apart in the industry. By leveraging thi...

We will tell you when either one moves

BounceWatch watches Archimedes Pharma and Disruptive Pharma AB for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Archimedes Pharma and Disruptive Pharma AB — by email.

Frequently Asked Questions

Archimedes Pharma — Specialty pharmaceutical company developing therapeutics for the treatment of chronic and debilitating illnesses. Disruptive Pharma AB — Creating a pipeline of drug products based on our novel drug delivery platform. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Archimedes Pharma has raised $329.00M while Disruptive Pharma AB has raised undisclosed funding.
Archimedes Pharma and Disruptive Pharma AB operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Archimedes Pharma with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Archimedes Pharma on 11 Mar 2026, and Disruptive Pharma AB on 22 Nov 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy